Mycophenolate mofetil and Letrozole drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Mycophenolate mofetil (mycophenolate mofetil) and Letrozole (letrozole). Common drug interactions include bone loss among females.
The phase IV clinical study analyzes what interactions people have when they take Mycophenolate mofetil and Letrozole. It is created by eHealthMe based on reports of 106 people who take the same drugs from the FDA, and is updated regularly.
What is Mycophenolate mofetil?
Mycophenolate mofetil has active ingredients of mycophenolate mofetil. It is often used in myasthenia gravis. eHealthMe is studying from 93,461 Mycophenolate mofetil users. Check the latest studies of Mycophenolate mofetil.
What is Letrozole?
Letrozole has active ingredients of letrozole. It is often used in breast cancer. eHealthMe is studying from 54,125 Letrozole users. Check the latest studies of Letrozole.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
106 people who take Mycophenolate mofetil and Letrozole together, and have interactions are studied.
What are the common drug interactions of Mycophenolate mofetil and Letrozole, by gender? *
What are the common drug interactions of Mycophenolate mofetil and Letrozole, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Mycophenolate mofetil and Letrozole?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Mycophenolate mofetil (93,461 reports)
- Letrozole (54,125 reports)
Browse all drug interactions of Mycophenolate mofetil and Letrozole:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Mycophenolate mofetil:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Letrozole:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Mycophenolate mofetil and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Letrozole and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on mycophenolate mofetil and letrozole (the active ingredients of Mycophenolate mofetil and Letrozole, respectively), and Mycophenolate mofetil and Letrozole (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Multiple Sclerosis and Prolactinoma - 3 seconds ago
- Gabapentin and Skin Hyperpigmentation for Women aged 50-59 - 7 seconds ago
- Could Enbrel cause Carotid Artery Disease? - 8 seconds ago
- Could Letairis cause Heart Palpitations? - 22 seconds ago
- Could Danazol cause Haematological Malignancy? - 24 seconds ago
- Could Sitagliptin cause Hyperglycemia? - 27 seconds ago
- Could Oxycodone cause Lymph Node Pain? - 34 seconds ago
- Miralax and Diarrhea for Men aged 20-29 - 35 seconds ago
- Miralax and Diarrhoea for Men aged 20-29 - 35 seconds ago
- Miralax and Stools - Watery for Men aged 20-29 - 35 seconds ago